Nuvation Bio, Inc. (NUVB)
3.99
-0.07
(-1.72%)
USD |
NYSE |
Nov 13, 16:00
3.98
-0.01
(-0.25%)
Pre-Market: 19:59
Nuvation Bio Net Income (Quarterly) : -41.90M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -41.90M |
| June 30, 2026 | -62.84M |
| March 31, 2026 | 5.397M |
| December 31, 2025 | -36.59M |
| September 30, 2025 | -55.79M |
| June 30, 2025 | -59.01M |
| March 31, 2025 | -53.24M |
| December 31, 2024 | -49.44M |
| September 30, 2024 | -41.21M |
| June 30, 2024 | -462.49M |
| March 31, 2024 | -14.79M |
| December 31, 2023 | -13.79M |
| September 30, 2023 | -19.65M |
| June 30, 2023 | -20.64M |
| Date | Value |
|---|---|
| March 31, 2023 | -21.73M |
| December 31, 2022 | -20.84M |
| September 30, 2022 | -27.20M |
| June 30, 2022 | -34.86M |
| March 31, 2022 | -21.29M |
| December 31, 2021 | -25.13M |
| September 30, 2021 | -21.98M |
| June 30, 2021 | -19.33M |
| March 31, 2021 | -20.40M |
| December 31, 2020 | -13.28M |
| September 30, 2020 | -11.03M |
| June 30, 2020 | -8.599M |
| March 31, 2020 | -8.746M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Pfizer Inc. | 3.251B |
| Johnson & Johnson | 210.00M |
| Merck & Co., Inc. | 5.067B |
| Bristol Myers Squibb Co. | 2.162B |
| ANI Pharmaceuticals, Inc. | 32.72M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 44.95M |
| Total Expenses (Quarterly) | 86.85M |
| EPS Diluted (Quarterly) | -0.1191 |
| Enterprise Value | 1.213B |
| Gross Profit Margin (Quarterly) | 72.18% |
| Profit Margin (Quarterly) | -93.21% |
| Earnings Yield | -9.81% |
| Normalized Earnings Yield | -9.404 |